Download Content

Nanofitin-Antibody fusion as a novel multispecific platform: providing extra specificities while maintaining developability

Please enter your details into the form below to access the Webinar on Nanofitin-Antibody Fusion as a Novel Multispecific Platform hosted with Mathieu Cinier, Scientific Director, Affilogic